Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Overcoming TGFβ-mediated immune evasion in cancer
Daniele V. F. Tauriello, Elena Sancho, Eduard Batlle
Nature reviews. Cancer (2021) Vol. 22, Iss. 1, pp. 25-44
Open Access | Times Cited: 221

Showing 1-25 of 221 citing articles:

Mitochondrial dynamics in health and disease: mechanisms and potential targets
Wen Chen, Huakan Zhao, Yongsheng Li
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 375
The cancer-immunity cycle: Indication, genotype, and immunotype
Ira Mellman, Daniel S. Chen, Thomas Powles, et al.
Immunity (2023) Vol. 56, Iss. 10, pp. 2188-2205
Open Access | Times Cited: 345
TGF-β signaling in health and disease
Joan Massagué, Dean Sheppard
Cell (2023) Vol. 186, Iss. 19, pp. 4007-4037
Open Access | Times Cited: 307
Mechanisms driving the immunoregulatory function of cancer cells
Antoinette van Weverwijk, Karin E. de Visser
Nature reviews. Cancer (2023) Vol. 23, Iss. 4, pp. 193-215
Closed Access | Times Cited: 140
Cancer-Associated Fibroblasts in Inflammation and Antitumor Immunity
Kilian B. Kennel, Müge Bozlar, Adalbert F. De Valk, et al.
Clinical Cancer Research (2022) Vol. 29, Iss. 6, pp. 1009-1016
Open Access | Times Cited: 128
Roles of cancer-associated fibroblasts (CAFs) in anti- PD-1/PD-L1 immunotherapy for solid cancers
Liping Pei, Yang Liu, Lin Liu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 113
NK cells and solid tumors: therapeutic potential and persisting obstacles
Le Tong, Carlos Jiménez‐Cortegana, Apple H.M. Tay, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 96
WNT signaling and cancer stemness
Masuko Katoh, Masaru Katoh
Essays in Biochemistry (2022) Vol. 66, Iss. 4, pp. 319-331
Open Access | Times Cited: 90
ATP and Adenosine Metabolism in Cancer: Exploitation for Therapeutic Gain
Gennady G. Yegutkin, Detlev Boison
Pharmacological Reviews (2022) Vol. 74, Iss. 3, pp. 799-824
Open Access | Times Cited: 88
Localization, tissue biology and T cell state — implications for cancer immunotherapy
Jason M. Schenkel, Kristen E. Pauken
Nature reviews. Immunology (2023) Vol. 23, Iss. 12, pp. 807-823
Open Access | Times Cited: 60
TGF-β, EMT, and resistance to anti-cancer treatment
Xuecong Wang, Pieter J.A. Eichhorn, Jean Paul Thiery
Seminars in Cancer Biology (2023) Vol. 97, pp. 1-11
Open Access | Times Cited: 52
The chemokine monocyte chemoattractant protein-1/CCL2 is a promoter of breast cancer metastasis
Teizo Yoshimura, Chunning Li, Yuze Wang, et al.
Cellular and Molecular Immunology (2023) Vol. 20, Iss. 7, pp. 714-738
Open Access | Times Cited: 50
The hallmarks of cancer immune evasion
Claudia Galassi, Timothy A. Chan, Ilio Vitale, et al.
Cancer Cell (2024) Vol. 42, Iss. 11, pp. 1825-1863
Closed Access | Times Cited: 49
Application of radiomics-based multiomics combinations in the tumor microenvironment and cancer prognosis
Wendi Kang, Xiang Qiu, Yingen Luo, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 44
Hepatocellular carcinoma: signaling pathways, targeted therapy, and immunotherapy
Xiaoting Luo, Xin He, Xingmei Zhang, et al.
MedComm (2024) Vol. 5, Iss. 2
Open Access | Times Cited: 30
Targeting inflammation as cancer therapy
Manni Wang, Siyuan Chen, Xuemei He, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 30
Mechanisms of metastatic colorectal cancer
Adrià Cañellas‐Socias, Elena Sancho, Eduard Batlle
Nature Reviews Gastroenterology & Hepatology (2024) Vol. 21, Iss. 9, pp. 609-625
Closed Access | Times Cited: 30
TME-Related Biomimetic Strategies Against Cancer
Cheng Peng, Yilin Xu, Jing Wu, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 109-135
Open Access | Times Cited: 27
Development of pharmacological immunoregulatory anti-cancer therapeutics: current mechanistic studies and clinical opportunities
Nanhao Yin, Xintong Li, Xuanwei Zhang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 19
TGF-β Modulated Pathways in Colorectal Cancer: New Potential Therapeutic Opportunities
Morena Fasano, Mario Pirozzi, Chiara Carmen Miceli, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7400-7400
Open Access | Times Cited: 17
Neutrophil Extracellular Traps, Angiogenesis and Cancer
Remo Poto, Leonardo Cristinziano, Luca Modestino, et al.
Biomedicines (2022) Vol. 10, Iss. 2, pp. 431-431
Open Access | Times Cited: 65
TGF-beta signal transduction: biology, function and therapy for diseases
Yan Tie, Fan Tang, Dandan Peng, et al.
Molecular Biomedicine (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 65
Toll-like receptor 9 agonists and combination therapies: strategies to modulate the tumour immune microenvironment for systemic anti-tumour immunity
Zhangchi Dongye, Jian Li, Yuzhang Wu
British Journal of Cancer (2022) Vol. 127, Iss. 9, pp. 1584-1594
Open Access | Times Cited: 62
Myeloid-Derived Suppressor Cells and Radiotherapy
Carlos Jiménez‐Cortegana, Claudia Galassi, Vanessa Klapp, et al.
Cancer Immunology Research (2022) Vol. 10, Iss. 5, pp. 545-557
Open Access | Times Cited: 55
TGF-β: A novel predictor and target for anti-PD-1/PD-L1 therapy
Ming Yi, Tianye Li, Mengke Niu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 53
Page 1 - Next Page

Scroll to top